Cantor Equity Partners I, a special purpose acquisition company affiliated with Cantor Fitzgerald, filed for a $200 million initial public offering. Howard Lutnick, chairman and chief executive ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 62.43% ...

Cantor Fitzgerald and Silverstein Properties have topped off Shorehaven, the first phase of South Pier, a $1.8 billion mixed-use development on Tempe Town Lake in Tempe, Ariz. The master-planned ...

Cantor Fitzgerald raised the firm’s price target on MicroStrategy (MSTR) to $312 from $200 and keeps an Overweight rating on the shares. MicroStrategy, whose core business is being a business ...

Western Digital (NASDAQ:WDC – Get Free Report) had its price target hoisted by stock analysts at Cantor Fitzgerald from $80.00 to $95.00 in a report released on Friday, Benzinga reports. The brokerage ...

Cantor Fitzgerald recently raised the price target on the stock to $225 from $200 and kept an Overweight rating on the shares into Q3 earnings season. The investment firm sees a tale of two ...

NEW YORK, Oct. 15, 2024 /PRNewswire/ -- Cantor Fitzgerald Infrastructure Fund (the "Fund") today announced a third-quarter distribution of $0.1170 per Class A share (NASDAQ: CAFIX), $0.1156 per Class ...

AMD analysts size up Q3 results and the disappointing Q4 guidance and what it means in a battle for market share with Nvidia.

On Monday, Cantor Fitzgerald maintained a positive stance on shares of HCA Healthcare Inc (NYSE: NYSE:HCA), raising the price target to $405 from the previous target of $392, while keeping an ...

Tuesday, Cantor Fitzgerald initiated coverage on Hive Digital Technologies (NASDAQ:HIVE) shares with an Overweight rating and a 12-month price target of $9.00. The firm highlighted HIVE's status ...

Hello, and welcome to the Teladoc Health's third quarter 2024 earnings call. My name is Alex, I'll be coordinating the call today. (Operator Instructions) I'll now hand over to your host, Michael ...